No Data
No Data
EBR Systems on Track to Submit Cardiac Pacing Technology's Final Module to US FDA in Q3
EBR Systems (ASX:EBR) is on track to submit in the third quarter the final module of its pre-market approval application to the US Food and Drug Administration for its wireless cardiac pacing system t
EBR Systems Price Target Raised 10% to A$1.43/Share by Bell Potter
EBR Systems Price Target Raised 10% to A$1.43/Share by Bell Potter
EBR Target Price Cut 3.9% to A$1.49/Share by Morgans>EBR.AU
EBR Target Price Cut 3.9% to A$1.49/Share by Morgans>EBR.AU
EBR Systems, Inc.'s (ASX:EBR) Top Owners Are Private Equity Firms With 41% Stake, While 28% Is Held by Institutions
EBR Systems Target Price Raised 10% to A$1.65/Share by Wilsons>EBR.AU
EBR Systems Target Price Raised 10% to A$1.65/Share by Wilsons>EBR.AU
EBR Systems Draws Down Second Tranche of AU$30 Million Under Growth Capital Facility
EBR Systems (ASX:EBR) drew down the second tranche of $20 million (AU$30.2 million) under a $50 million growth capital facility with Runway Growth Capital, according to a Monday news release.
No Data